pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$LCTXLineage Cell Therapeutics, Inc.

$LCTX
Carlsbad, CA, USupdated 2mo ago

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials.

SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Phase 2: 1
1Phase 2
Phase 2
OPC-1
Acute Spinal Cord Injury
5-hydroxytryptamine receptor 2AD(2) dopamine receptor

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase1A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injuryrecruitingn=10
  • —LTFU Study of Subjects Who Received GRNOPC1active not recruitingn=5
  • —LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1active not recruitingn=25

Insider activity

source: SEC Form 4

open-market buys + sells

  • Mar 12, 26BUYCulley Brian M· President and CEO15,000 sh @ $1.63$24K↗
routine RSU / option mechanics (3)
  • Mar 5, 26grantCulley Brian M · President and CEO3,250,000 sh
  • Mar 5, 26grantHowe Jill Ann · Chief Financial Officer1,050,000 sh
  • Mar 5, 26grantSamuel George A. III · General Counsel and Secretary900,000 sh
🐶 Hiring Signal
No open roles indexed yet — view Lineage Cell Therapeutics, Inc. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$LCTX
SEC CIK
0000876343
country
US
source
sec_tickers
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 18m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?